Cases & Deals

IntegraGen closes €6.72 million private placement and subsequent IPO

Clients IntegraGen

Jones Day advised IntegraGen, a pioneer in the development of molecular diagnostic products and services, in connection with its €6.72 million (US$8.3 million) private placement to qualified investors, including BIOAM Gestion, CDC Enterprises, CDC Innovation, and IDInvest Partners, and subsequent initial public offering on the Alternext Market of NYSE Euronext Paris.